{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T23:23:43Z","timestamp":1771457023710,"version":"3.50.1"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T00:00:00Z","timestamp":1671494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>There is a large population of people with spinal muscular atrophy (SMA) in China, and new disease-modifying therapies have become available recently. However, comprehensive data on the management and profile of treatment-naive SMA patients in China are still lacking.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>As a retrospective study, a large cohort of treatment-naive patients with clinical and genetic diagnoses of 5q SMA were enrolled, ranging from neonatal to 18 years old, from the Neurology Department of Children's Hospital of Fudan University between January 2013 and December 2020. The data regarding their clinical presentations, genetic defects, motor function assessment results, and follow ups were reviewed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We enrolled 392 SMA patients (male: female = 189: 203): 1a = 46, 1b = 44, 1c = 31, 2a = 119, 2b = 56, 3a = 52, 3b = 14, from 27 of the 34 administrative districts in China, and 389 patients harbored homozygous deletion of exon 7 in the SMN1 gene (99.2%). The median age of onset was 0.08 (range: 0\u20130.30), 0.25 (0.06\u20130.60), 0.42 (0.08\u20131.50), 0.67 (0.07\u20135.08), 1.0 (0.40\u20131.83), 1.5 (1.00\u20133.00), and 4.04 (1.80\u201312.00) years old for SMA 1a, 1b, 1c, 2a, 2b, 3a, and 3b patients, while the median age of first assessment was 0.25 (0.08\u20132.60), 0.42 (0.17\u20131.90), 0.80 (0.17\u20134.5), 2.50 (0.5\u201315.83), 2.92 (1.08\u201313.42), 4.25 (1.58\u201317.33), and 7.34 (3.67\u201314.00) years old, respectively. Patients were followed up with for up to 15.8 years. The median event-free survival time was 7 months, 15 months, and indeterminate in SMA 1a, 1b, and 1c patients (<jats:italic>p<\/jats:italic> &amp;lt; 0.0001), with a better survival situation for higher SMN2 copies (<jats:italic>p<\/jats:italic> = 0.0171). The median age of sitting loss was 5.75 years and 13.5 years in SMA 2a and 2b (<jats:italic>p<\/jats:italic> = 0.0214) and that of ambulation loss was 9.0 years and undefined in SMA 3a and 3b (<jats:italic>p<\/jats:italic> = 0.0072). Cox regression analysis showed that higher SMN2 copies indicated better remaining ambulation in SMA 3. The median time to develop orthopedic deformities was 4.5, 5.2, and 10.1 years in SMAs 1c, 2, and 3, respectively (<jats:italic>p<\/jats:italic> &amp;lt; 0.0001), with a possible trend of better preservation of joint function for patients under regular rehabilitation (<jats:italic>p<\/jats:italic> = 0.8668).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our study elucidated insight into the comprehensive management and profile of different types of SMA patients in China, providing a clinical basis for assessing the efficacy of new therapies.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2022.1038012","type":"journal-article","created":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T07:54:44Z","timestamp":1671522884000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Comprehensive profile and natural history of pediatric patients with spinal muscular atrophy: A large retrospective study from China"],"prefix":"10.3389","volume":"13","author":[{"given":"Chaoping","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xihua","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiyun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaomei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenhui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuizhen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/(SICI)1098-1004(200003)15:3<228::AID-HUMU3>3.0.CO;2-9","article-title":"An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA)","volume":"15","author":"Wirth","year":"2000","journal-title":"Hum Mutat."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1086\/302369","article-title":"Quantitative analysis of survival motor neuron copies: identification of subtle SMN1 mutations in patients with spinal muscular atrophy, genotype-phenotype correlation, and implications for genetic counseling","volume":"64","author":"Wirth","year":"1999","journal-title":"Am J Hum Genet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1016\/S0140-6736(08)60921-6","article-title":"Spinal muscular atrophy","volume":"371","author":"Lunn","year":"2008","journal-title":"Lancet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/ejhg.2010.54","article-title":"Molecular characterization of SMN copy number derived from carrier screening and from core families with SMA in a Chinese population","volume":"18","author":"Sheng-Yuan","year":"2010","journal-title":"Eur J Hum Genet."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e18975","DOI":"10.1097\/MD.0000000000018975","article-title":"The prevalence of spinal muscular atrophy carrier in China: Evidences from epidemiological surveys","volume":"99","author":"Li","year":"2020","journal-title":"Medicine."},{"key":"B6","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1177\/0883073811420152","article-title":"The natural history of infant spinal muscular atrophy in China: a study of 237 patients","volume":"27","author":"Ge","year":"2012","journal-title":"J Child Neurol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.braindev.2020.07.012","article-title":"Natural history in spinal muscular atrophy type I in Taiwanese population: a longitudinal study","volume":"43","author":"Ou","year":"2021","journal-title":"Brain Dev."},{"key":"B8","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1002\/ana.20473","article-title":"Natural history of denervation in SMA: relation to age, SMN2 copy number, and function","volume":"57","author":"Swoboda","year":"2005","journal-title":"Ann Neurol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.nmd.2016.10.002","article-title":"Developmental milestones in type I spinal muscular atrophy","volume":"26","author":"De Sanctis","year":"2016","journal-title":"Neuromuscul Disord."},{"key":"B10","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.nmd.2017.09.015","article-title":"Clinical phenotypes and trajectories of disease progression in type 1 spinal muscular atrophy","volume":"28","author":"De Sanctis","year":"2018","journal-title":"Neuromuscul Disord."},{"key":"B11","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13023-020-01356-1","article-title":"Longitudinal natural history of type I spinal muscular atrophy: a critical review","volume":"15","author":"Mercuri","year":"2020","journal-title":"Orphanet J Rare Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1002\/ana.25101","article-title":"Natural history of infantile-onset spinal muscular atrophy","volume":"82","author":"Kolb","year":"2017","journal-title":"Ann Neurol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1001\/archneurol.2010.373","article-title":"Observational study of spinal muscular atrophy type 2 and 3: functional outcomes over 1 year","volume":"68","author":"Kaufmann","year":"2011","journal-title":"Arch Neurol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1212\/WNL.0b013e318271f7e4","article-title":"Prospective cohort study of spinal muscular atrophy types 2 and 3","volume":"79","author":"Kaufmann","year":"2012","journal-title":"Neurology."},{"key":"B15","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s13023-021-01771-y","article-title":"Observation of the natural course of type 3 spinal muscular atrophy: data from the polish registry of spinal muscular atrophy","volume":"16","author":"Lusakowska","year":"2021","journal-title":"Orphanet J Rare Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1038\/s41431-019-0415-4","article-title":"Perspectives in genetic counseling for spinal muscular atrophy in the new therapeutic era: early pre-symptomatic intervention and test in minors","volume":"27","author":"Serra-Juhe","year":"2019","journal-title":"Eur J Hum Genet."},{"key":"B17","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1086\/338627","article-title":"Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy","volume":"70","author":"Feldk\u00f6tter","year":"2002","journal-title":"Am J Hum Genet."},{"key":"B18","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1007\/s00439-006-0156-7","article-title":"Mildly affected patients with spinal muscular atrophy are partially protected by an increased SMN2 copy number","volume":"119","author":"Wirth","year":"2006","journal-title":"Hum Genet."},{"key":"B19","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1212\/WNL.0000000000000741","article-title":"Observational study of spinal muscular atrophy type I and implications for clinical trials","volume":"83","author":"Finkel","year":"2014","journal-title":"Neurology."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e1634","DOI":"10.1212\/WNL.0000000000009248","article-title":"Population-based analysis of survival in spinal muscular atrophy","volume":"94","author":"Wijngaarde","year":"2020","journal-title":"Neurology."},{"key":"B21","first-page":"19","article-title":"Early infantile form of spinal muscular atrophy (Werdnig-Hoffmann disease) with prolonged survival","volume":"40","author":"Borkowska","year":"2002","journal-title":"Folia Neuropathol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.nmd.2015.04.009","article-title":"209th ENMC international workshop: outcome measures and clinical trial readiness in spinal muscular atrophy 7-9 November 2014, Heemskerk, The Netherlands","volume":"25","author":"Finkel","year":"2015","journal-title":"Neuromuscul Disord."},{"key":"B23","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.nmd.2015.10.006","article-title":"Patterns of disease progression in type 2 and 3 SMA: implications for clinical trials","volume":"26","author":"Mercuri","year":"2016","journal-title":"Neuromuscul Disord."},{"key":"B24","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.nmd.2020.07.004","article-title":"Gain and loss of abilities in type II SMA: a 12-month natural history study","volume":"30","author":"Coratti","year":"2020","journal-title":"Neuromuscul Disord."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1002\/ana.25900","article-title":"Clinical variability in spinal muscular atrophy type III","volume":"88","author":"Coratti","year":"2020","journal-title":"Ann Neurol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/ene.13534","article-title":"Muscle strength and motor function throughout life in a cross-sectional cohort of 180 patients with spinal muscular atrophy types 1c-4","volume":"25","author":"Wadman","year":"2018","journal-title":"Eur J Neurol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13023-022-02227-7","article-title":"Natural history of respiratory muscle strength in spinal muscular atrophy: a prospective national cohort study","volume":"17","author":"Veldhoen","year":"2022","journal-title":"Orphanet J Rare Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"453","DOI":"10.3233\/JND-200508","article-title":"Natural history of type 1 spinal muscular atrophy in a series of argentinian children","volume":"7","author":"Aguerre","year":"2020","journal-title":"J Neuromuscul Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.nmd.2021.03.002","article-title":"Factors associated with delayed diagnosis of spinal muscular atrophy in China and changes in diagnostic delay","volume":"31","author":"Cao","year":"2021","journal-title":"Neuromuscul Disord."},{"key":"B30","doi-asserted-by":"publisher","first-page":"398","DOI":"10.3760\/cma.j.cn112140-20191225-00832","volume":"58","author":"Ge","year":"2020","journal-title":"Zhonghua Er Ke Za Zhi."},{"key":"B31","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.nmd.2021.08.010","article-title":"Natural history of 10-meter walk\/run test performance in spinal muscular atrophy: a longitudinal analysis","volume":"32","author":"Krosschell","year":"2022","journal-title":"Neuromuscul Disord."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.1038012\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T07:54:49Z","timestamp":1671522889000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.1038012\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,20]]},"references-count":31,"alternative-id":["10.3389\/fneur.2022.1038012"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2022.1038012","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,20]]},"article-number":"1038012"}}